3^rd Euro-Global Summit on Probiotics & Nutraceuticals August 24-25, 2022 Barcelona, Spain

Franco Vicariotto, Medicine Doctor (Ph.D.medicine), is a specialist in Obstetrics and Gynecology and is now senior consultant of San PIO X Hospital of Milan. He has been deputy head of division of Ob/Gyn. of Niguarda Hospital of Milan for almost 20 years where he had conducted important researches in the field of Infectious Diseases in Obstetrics and Gynecology. He is one of the founders and Vice-president of the scientific society Esidog Italia (European Society for Infectious Diseases in Obstetrics and Gynaecology) and the member of the National board of S.I.C. (Italian society of Contraception). He is author of many publications and recognized moderator-spokesman in specialized conferences in Italy and abroad.

Franco Vicariotto is a specialist in Obstetrics and Gynecology

Antonello Santini has a PhD in Chemical Sciences, University of Napoli, Italy, 1992. He is a Research Associate, Department of Chemistry, 1993-1994, National Research Council Fellow, University of Napoli, 1994-1995, Appointed to Faculty, University of Napoli, 1994-Department of Food Science and since 2012 Department of Pharmacy. He has published more than 110 papers in reputed international journals. He is the Editor in Chief, Food Science and Technology Letters, 2011. He is Editor in Chief of Journal of Food Research, 2012; Member of the European Food Safety Authority EFSA, ERWG, Parma, Italy; Member of Managing Board, Italian Chemistry Society (SCI) Division of Teaching (DD-SCI), Rome, Italy. His teaching includes Food Chemistry, General and Inorganic Chemistry, Laboratory of Chemistry. His research activity focuses on food chemistry, nutraceuticals, food contaminants, mycotoxins and secondary metabolites and food analysis.

Antonello has interest in Food Chemistry, General and Inorganic Chemistry, Laboratory of Chemistry. His research activity focuses on food chemistry, nutraceuticals, food contaminants, mycotoxins and secondary metabolites and food analysis.

Alexander Sulakvelidze, Ph.D, is an Associate Professor of Molecular Genetics and Microbiology at the University of Florida College of Medicine, and Chief Scientist and Vice-President for Research & Development of Intralytix, Inc. Dr. Sulakvelidze is an internationally recognized expert in phage technology and infectious disease epidemiology. He has served/is serving as the Principal Investigator/Project Director of several grants and contracts from various agencies and foundations, including the National Institutes of Health (NIH), United States Department of Defense (DOD), United States Environmental Protection Agency (EPA), United States Department of Agriculture (USDA), National Food Processors Association (NFPA), Department of Health and Human Services Biotechnology Engagement Program (BTEP), and the Civilian Research and Development Foundation (CRDF). Sulakvelidze has published extensively on the subjects of molecular epidemiology and phage therapy, and he is the author of several issued and pending patents in the field of bacteriophages. He also co-edited a major book about bacteriophages, which was published by the CRC Press in 2005. Dr. Sulakvelidze serves as Editor-in-Chief of the journal Bacteriophage. His research has been featured in several magazines and newspapers (including the Los Angeles Times, Newsweek, Science, Smithsonian, Wired, and Discover Magazine), and in various radio programs and television documentaries (including National Public Radio’s Science Friday, BBC Radio and Voice of America radio programs, and BBC Horizon documentary about phage therapy). Dr. Sulakvelidze serves as an ad hoc reviewer for various journals, such as Antimicrobial Agents and Chemotherapy, Applied and Environmental Microbiology, Drug Discovery Today, FEMS Immunology and Medical Microbiology, FEMS Microbiology Letters, Clinical and Experimental Dermatology, Food Microbiology, Trends in Biotechnology, Journal of Clinical Microbiology, and Therapeutic Delivery, and for several funding agencies, including the CRDF, the International Science and Technology Center (ISTC), the Qatar Research Fund, the U.S.-Israel Binational Science Foundation (BSF), and the NIH.

“Molecular epidemiology and phage biocontrol approaches, including applications of bacteriophages for improving food safety and microbiome composition”

Ascension Marcos got her PhD at the School of Pharmacy at the Complutense University in Madrid, Spain (UCM) in 1982 and Master in Clinical Analysis by UCM in 1986, and got a grant at the Spanish National Research Council (CSIC). She was the Head of the Institute of Nutrition and Food Technology at the Mixed Center CSIC-UCM (1998-2002). She is the leader of the Immunonutrition Research Group at the Department of Metabolism and Nutrition at CSIC since 1987. She achieved the highest category at CSIC as a Research Professor in 2006 and her scientific consolidation has been recognized for 5 six-year terms since 1985. She is a pioneer in the field of Immunonutrition in Spain, Founder and President of the International Forum of Immunonutrition for Education and Research (i-FINER)since 2007. In 2014 the i-FINER group has developed the International Society for Immunonutrition (ISIN), she being also the President.

Probiotics

Dr. Iryna Sorokulova, Professor of Microbiology, Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA. She received her MS degree in Microbiology from Taras Shevchenko Kiev State University (Ukraine) and Ph.D. and D.Sc. Degrees in Microbiology from Institute of Microbiology and Virology, National Academy of Sciences of Ukraine. Dr. Sorokulova received professional training at Moscow State University (Russia), Bureau of Biologics (Ottawa, Canada), Massachusetts Biological Laboratories (Boston, MA, USA). She is the recipient of the Ukraine State Prize in Science and Technology. Dr. Sorokulova is the author of 76 refereed scientific publications, 4 books, and 23 patents (1- US, 1-France; 6-Ukraine, 15-Russia). Six patents are now licensed and commercialized. She created several biotechnological products; some of them are commercially available.

Development of Bacillus therapeutics • Safety assessment of bacterial strains, prospective as food and drugs • Elaboration of new diagnostic probes for detection of pathogens • New methods of bacteria formulations for prolongation of shelf-life and stabilization during the storage • Evaluation of the criteria for recombinant probiotics

Stefan R Herbel is working as a GMP Compliance Manager in the Department of Microbiology at Bayer HealthCare in Grenzach-Wyhlen, Germany. His work includes monitoring and guiding the good manufacturing practice standards in producing ointments and ready-to-use injections. In 2010 he started working on his Ph.D. at the Institute of Microbiology and Epizootics at the Department of Veterinarian Medicine (Freie Universität Berlin). In his project he was establishing a rapid and reliable real-time PCR technique for species-specific identification and quantification of probiotics in dairy and non-dairy products such as pharmaceuticals, food samples and non-food articles. After studying Biology at the Freie Universität in Berlin he was working as a Second Head of the diagnostic laboratories at Biotecon Diagnostics GmbH in Potsdam, Germany. He is a peer reviewer for a numer of journals dealing with probiotics: African Journal of Microbiology Research, Berliner und Münchener tierärztliche Wochenschrift, British Journal of Nutrition, Folia Microbiologica, Journal of Microbiology Research & Reviews, Journal of Proteomics & Bioinformatics, PLoS ONE and SpringerPlus. In addition, his research has received recognistion and commendation at different conferences and annual meetings such as at 16th International Symposium of the World Association of Veterinary Laboratory Diagnosticians (WAVLD)”, Berlin, Germany (2013), 7th Yakult Symposium 2013, London, Great Britain (2013), International Conference and Exhibition on Probiotics 2012”, OMICS Group, San Antonio, USA (2012), Seeon Conference ‘Microbiota, Probiota and Host’, DGHM, Seeon, Germany (2012, 2013), International Probiotic Conference 2012, Kosice, Slovakia (2012) and Probiotics, Prebiotics & New Foods, Rome, Italy (2011). Finally, his oral presentation at the “International Conference and Exhibition on Probiotics 2012”, OMICS Group, San Antonio, USA (2012) had been ranked as the best talk within the Young Scientist Challenge Trophy Competition.

Testing, developing different diagnostic tools for a rapid identification of health beneficial bacteria in yoghurt, cereals, tablets, straws and other probiotic products.

Svetoslav Todorov has completed his PhD at Sofia University, Sofia, Bulgaria and postdoctoral studies from Stellenbosch University, Matieland, South Africa. At the moment, he is visiting professor at Sao Paulo University, Faculty of Pharmaceutical Sciences, Sao Paulo, Brazil. He has published more than 90 papers in reputed journals and serving as a member of the editorial board. He is reviewer for more than 30 international journals.

Molecular taxonomy of lactic acid bacteria isolated from fermented foods; Characterization of bacteriocins produced by lactic acid bacteria; Purification of polypeptides and small proteins; Probiotic lactic acid bacteria; Physiology and biochemistry of lactic acid bacteria; Medical application of the bacteriocins produced by lactic acid bacteria.

Dr Izzeldin Abuelaish is a Palestinian doctor and infertility specialist. In 2009 three of his daughters were killed by Israeli shells. He now campaigns for peace and teaches at the University of Toronto.

Global Public Health, Women's Health, Health Conflict and Peace